ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SABSW SAB Biotherapeutics Inc

0.035
0.0046 (15.13%)
After Hours
Last Updated: 16:02:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
SAB Biotherapeutics Inc SABSW NASDAQ Equity Warrant
  Price Change Change Percent Stock Price Last Traded
0.0046 15.13% 0.035 16:02:00
Open Price Low Price High Price Close Price Prev Close
0.035 0.035 0.035 0.035 0.0304
more quote information »

Recent News

Date Time Source Heading
4/30/20248:53IHNWFeaturedCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
4/16/202407:15GLOBESAB Biotherapeutics Provides SAB-142 Trial Update
4/08/202407:15GLOBESAB Biotherapeutics to Present at INNODIA Annual Meeting
4/04/202407:15GLOBESAB Biotherapeutics to Present at the Needham Virtual..
3/29/202407:15GLOBESAB Biotherapeutics Reports Full Year 2023 Operating and..
3/25/202410:15GLOBESAB Biotherapeutics Announces Clinical Partnership with..
2/23/202408:00GLOBESAB Biotherapeutics to Present at the BIO CEO & Investor..
2/08/202408:00GLOBESAB Biotherapeutics to Present at the Oppenheimer..
2/02/202407:30GLOBESAB Biotherapeutics Announces Executive Leadership Change
1/23/202417:58GLOBESAB Biotherapeutics Regains Compliance with Nasdaq Minimum..
1/02/202416:30GLOBESAB Biotherapeutics Announces 1-for-10 Reverse Stock Split
11/29/202307:30GLOBESAB Biotherapeutics Announces Commencement of the HUMAN..
11/20/202307:30GLOBESAB Biotherapeutics Appoints Katie Ellias to the Board of..
11/14/202307:30GLOBESAB Biotherapeutics Announces Completion of $67.1 Million..
11/14/202307:15GLOBESAB Biotherapeutics Announces Q3 2023 Financial Results and..
11/09/202307:30GLOBESAB Biotherapeutics to Present at Piper Sandler Healthcare..
10/24/202307:30GLOBESAB Biotherapeutics Appoints Michael G. King Jr. as Chief..
10/19/202307:30GLOBESAB Biotherapeutics Receives Australian Approval to Commence..
10/05/202307:30GLOBESAB Biotherapeutics Approves Appointment of Andrew Moin to..
10/02/202307:30GLOBESAB Biotherapeutics Announces Private Placement of up to..
8/21/202308:30GLOBESAB Biotherapeutics Provides Company Update for Q2..
6/21/202308:30GLOBESAB Biotherapeutics Presents Positive IND-Enabling GLP..
5/30/202308:30GLOBESAB Biotherapeutics to Present Novel Human IgG Platform with..
5/19/202308:30GLOBESAB Biotherapeutics Presents Virtual 2023 R&D Day Portfolio..
5/16/202308:30GLOBESAB Biotherapeutics Provides Company Update for Q1 2023..
5/12/202308:30GLOBESAB Biotherapeutics Announces First Publication of Promising..
5/09/202308:30GLOBESAB Biotherapeutics Announces Progress on U.S. FDA’s Phased..
5/04/202308:30GLOBESAB Biotherapeutics Presents Positive Phase 1 and 2a Data..
5/03/202317:00GLOBESAB Biotherapeutics to Present at Sidoti Virtual Investor..

Your Recent History

Delayed Upgrade Clock